These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12115253)

  • 21. TNF inhibition in SLE: where do we stand?
    Aringer M; Smolen JS
    Lupus; 2009 Jan; 18(1):5-8. PubMed ID: 19074162
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful etanercept treatment of constrictive pericarditis complicating rheumatoid arthritis.
    Aslangul E; Perrot S; Durand E; Mousseaux E; Le Jeunne C; Capron L
    Rheumatology (Oxford); 2005 Dec; 44(12):1581-3. PubMed ID: 16204377
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
    Guillevin L; Mouthon L
    J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Schiff MH
    Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
    Yazdani-Biuki B; Stadlmaier E; Mulabecirovic A; Brezinschek R; Tilz G; Demel U; Mueller T; Brickmann K; Graninger WB; Brezinschek HP
    Ann Rheum Dis; 2005 Aug; 64(8):1224-6. PubMed ID: 16014683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S
    J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318
    [No Abstract]   [Full Text] [Related]  

  • 29. Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade.
    Ravindran J; Shenker N; Bhalla AK; Lachmann H; Hawkins P
    Rheumatology (Oxford); 2004 May; 43(5):669-72. PubMed ID: 15103032
    [No Abstract]   [Full Text] [Related]  

  • 30. An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti-tumor necrosis factor therapy: comment on the article by Dixon et al.
    Holman AJ
    Arthritis Rheum; 2008 Jun; 58(6):1886; author reply 1886. PubMed ID: 18512805
    [No Abstract]   [Full Text] [Related]  

  • 31. TNFalpha therapy in psoriatic arthritis and psoriasis.
    Mease P
    Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-tumor necrosis factor-alpha-induced psoriasis.
    Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
    J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P
    JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 36. Nephrotic syndrome associated with anti-tumor necrosis factor alpha therapy in a patient with rheumatoid arthritis: comment on the article by Charles et al.
    den Broeder AA; Assmann KJ; van Riel PL; Wetzels JF
    Arthritis Rheum; 2002 Jun; 46(6):1691-3; author reply 1693. PubMed ID: 12115204
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
    Hall HA; Zimmermann B
    Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.
    Wolfe F; Michaud K
    Am J Med; 2004 Mar; 116(5):305-11. PubMed ID: 14984815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
    Watson P; Simler N; Screaton N; Lillicrap M
    Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.